Venezuelan expert on leprosy dead at 100

May 12, 2014

Venezuelan scientist and doctor Jacinto Convit, renowned for developing a vaccine against leprosy, died on Monday in Caracas at the age of 100, his family said.

Convit won many international honors, including Spain's Prince of Asturias Award and France's Legion of Honor, and was tipped for the 1988 Nobel Prize for Medicine, although he did not win.

understanding of infectious and such as Leishmaniasis and Chagas.

In the past 15 years, he devoted much of his time looking for a cure for cancer.

"This disease prevents me from sleeping," he confided in 2013.

In a statement announcing his death, his family said that Convit had spent much of his career working to cure diseases threatening the native peoples of Venezuela's tropical forests and .

Explore further: Potential cure for Chagas disease

Related Stories

Potential cure for Chagas disease

October 25, 2012
A Murdoch University international collaborative project has found a potential cure for the deadly Chagas disease.

Drive behind Nobel Medicine Prize say winners

October 7, 2013
A German-born neuroscientist who describes himself as "incredibly driven" was actually driving around in Spain when his phone rang Monday with the news that he'd won the Nobel Prize.

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.